CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
May 15th 2024
The Food and Drug Administration approved Breyanzi for patients with pretreated, relapsed or refractory follicular lymphoma.